• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人外周脂肪组织器官培养中骨作用细胞因子的表达和调节。

The expression and regulation of bone-acting cytokines in human peripheral adipose tissue in organ culture.

机构信息

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark.

出版信息

Horm Metab Res. 2011 Jun;43(7):477-82. doi: 10.1055/s-0031-1277156. Epub 2011 May 10.

DOI:10.1055/s-0031-1277156
PMID:21560112
Abstract

The humoral cross-talk between bone and fat is an area of increasing interest. We investigated the expression and regulation of the bone-acting cytokines; bone morphogenetic protein 2 (BMP2), connective tissue growth factor (CTGF), osteoprotegerin (OPG), and transforming growth factor beta (TGFB1). Subcutaneous adipose tissue was aspirated from lean, healthy women. Tissue samples were incubated with interleukin 1-β (IL1-β), tumor necrosis factor-α (TNF-α), cortisol, troglitazone, IL1-β + troglitazone, or vehicle. Gene expression in the adipose tissue was analyzed using qPCR and protein levels in the incubation media were analyzed using ELISA. OPG expression and secretion was diminished by 40.8% and 43.1% respectively, by cortisol, and OPG expression was diminished by 67.5% by troglitazone (p<0.05). The proinflammatory cytokines IL1-β and TNF-α significantly increased the expression of CTGF (p<0.05) by 65.1% and 101.3%, respectively, and the expression and secretion of OGP by 62.3-165.8% (p<0.05). This interleukin 1-β mediated increase in CTGF- and OPG expression and secretion was ameliorated by troglitazone. Troglitazone and related drugs are known to have adverse effects on bone. We suggest that this could be mediated via altered cytokine production in adipose tissue. Moreover, obese individuals have a low-grade inflammation in their adipose tissue and have higher bone mineral density than lean individuals. We suggest that this inflammation may increase the expression and secretion of OPG and CTGF and thereby increase BMD. In conclusion, bone acting cytokines are produced in the adipose tissue and may affect bone through endocrine mechanisms.

摘要

骨与脂肪之间的体液相互作用是一个日益受到关注的领域。我们研究了骨作用细胞因子的表达和调节,包括骨形态发生蛋白 2(BMP2)、结缔组织生长因子(CTGF)、护骨素(OPG)和转化生长因子β(TGFB1)。从健康的瘦人身上抽吸皮下脂肪组织。将组织样本与白细胞介素 1-β(IL1-β)、肿瘤坏死因子-α(TNF-α)、皮质醇、曲格列酮、IL1-β+曲格列酮或载体孵育。使用 qPCR 分析脂肪组织中的基因表达,使用 ELISA 分析孵育介质中的蛋白水平。皮质醇使 OPG 的表达和分泌分别减少了 40.8%和 43.1%,曲格列酮使 OPG 的表达减少了 67.5%(p<0.05)。促炎细胞因子 IL1-β 和 TNF-α 分别使 CTGF 的表达增加了 65.1%和 101.3%(p<0.05),并使 OPG 的表达和分泌增加了 62.3-165.8%(p<0.05)。这种白细胞介素 1-β 介导的 CTGF 和 OPG 表达和分泌的增加被曲格列酮改善。曲格列酮和相关药物已知对骨骼有不良影响。我们认为,这可能是通过改变脂肪组织中细胞因子的产生来介导的。此外,肥胖个体的脂肪组织存在低度炎症,并且比瘦个体具有更高的骨矿物质密度。我们认为,这种炎症可能会增加 OPG 和 CTGF 的表达和分泌,从而增加 BMD。总之,骨作用细胞因子在脂肪组织中产生,并可能通过内分泌机制影响骨骼。

相似文献

1
The expression and regulation of bone-acting cytokines in human peripheral adipose tissue in organ culture.人外周脂肪组织器官培养中骨作用细胞因子的表达和调节。
Horm Metab Res. 2011 Jun;43(7):477-82. doi: 10.1055/s-0031-1277156. Epub 2011 May 10.
2
Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.曲格列酮对原代培养的人脂肪细胞前体细胞中肿瘤坏死因子α及转化生长因子β表达和作用的影响
Metabolism. 2006 Mar;55(3):309-16. doi: 10.1016/j.metabol.2005.09.004.
3
Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.骨折愈合过程中骨保护素、核因子-κB受体激活剂配体(骨保护素配体)及相关促炎细胞因子的表达
J Bone Miner Res. 2001 Jun;16(6):1004-14. doi: 10.1359/jbmr.2001.16.6.1004.
4
Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.非肥胖和肥胖受试者皮下与网膜脂肪组织中纤溶酶原激活物抑制剂1的差异。
Horm Metab Res. 2003 Mar;35(3):178-82. doi: 10.1055/s-2003-39078.
5
Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.腹部脂肪组织细胞因子基因表达:与肥胖及代谢危险因素的关系。
Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E741-7. doi: 10.1152/ajpendo.00419.2004. Epub 2004 Nov 23.
6
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.人成骨细胞系细胞产生骨保护素受维生素D、骨形态发生蛋白-2和细胞因子的刺激。
Biochem Biophys Res Commun. 1998 Sep 29;250(3):776-81. doi: 10.1006/bbrc.1998.9394.
7
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.白细胞介素(IL)-18通过类风湿关节炎中的滑膜T细胞刺激破骨细胞形成:与IL-1β和肿瘤坏死因子α的比较
Ann Rheum Dis. 2004 Nov;63(11):1379-86. doi: 10.1136/ard.2003.018481.
8
Obesity-associated proinflammatory cytokines increase calcium sensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line.肥胖相关的促炎细胞因子增加原代人脂肪细胞和 LS14 人脂肪细胞系中的钙敏感受体 (CaSR) 蛋白表达。
Arch Biochem Biophys. 2010 Aug 15;500(2):151-6. doi: 10.1016/j.abb.2010.05.033. Epub 2010 Jun 4.
9
Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.细胞因子调控人及小鼠滑膜成纤维细胞中RANKL和骨保护素的表达:成纤维细胞介导的病理性骨吸收
Arthritis Rheum. 2008 Aug;58(8):2397-408. doi: 10.1002/art.23653.
10
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.重型β地中海贫血相关骨质疏松症中“活跃”的细胞因子网络
Bone. 2007 Jun;40(6):1588-94. doi: 10.1016/j.bone.2007.02.020. Epub 2007 Mar 1.

引用本文的文献

1
Osteoprotegerin in Cardiometabolic Disorders.骨保护素与心脏代谢紊乱
Int J Endocrinol. 2015;2015:564934. doi: 10.1155/2015/564934. Epub 2015 May 11.
2
Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease.流式细胞术检测克罗恩病患者维生素D治疗期间维生素D受体的变化
Clin Exp Immunol. 2015 Jul;181(1):19-28. doi: 10.1111/cei.12613. Epub 2015 May 5.
3
Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.
多囊卵巢综合征患者的血浆骨保护素与睾酮水平相关,但不受吡格列酮治疗的影响。
J Endocrinol Invest. 2013 Jul-Aug;36(7):460-5. doi: 10.3275/8767. Epub 2012 Nov 26.